Dr Robin Brown is the Chairman of Medicines Discovery Catapult having most recently been CEO of KWS BioTest, prior to that Robin spent eight years as a venture partner at Advent Healthcare Ventures and was responsible for a number of companies within the investment portfolio. He was also the Chief Scientific Officer of Devgen and Galapagos (EBR:DEVG, EBR:GLPG), both of which are now publically listed companies. Robin spent nine years at GSK, latterly as Head of Cell Biology and as an academic gained his PhD in the laboratory of Prof Alan Hall. He undertook postdoctoral work in the United States (Harvard) and London (Ludwig Institute).
Dr Robin Brown